NanoViricides Inc.

AMEX: NNVC · Real-Time Price · USD
1.49
0.02 (1.71%)
At close: Aug 15, 2025, 3:59 PM
1.49
0.00%
After-hours: Aug 15, 2025, 07:35 PM EDT

NanoViricides Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
-2.22M -2.03M -3.13M -2.36M -1.85M -2.11M -1.97M -3.57M -1.7M -1.75M -1.57M -1.78M -1.79M -1.92M -2.61M -2.07M -2.11M -2.33M -2.31M
Depreciation & Amortization
184.98K 195.88K 195.61K 190.6K 189.96K 189.33K 189.12K 188.88K 188.32K 186.92K 183.4K 187.96K 181.56K 177.39K 176.42K 176.16K 176.14K 175K 177.23K
Stock-Based Compensation
-65.85K 52.26K 60.16K -130.61K 54.78K 47.61K 71.47K 50.45K 60.3K 51.3K 52.11K 103.74K 84.42K 75.37K 74.89K 93.11K 128.54K 92.6K 91.35K
Other Working Capital
158.13K -180.97K 22.84K 93.83K -117.73K -3.14K 318.1K 1.59M -177.95K 164.25K 103.34K 14.38 -5.69K 53.86K 111.21K 24.51K -473 105.39K 41.22K
Other Non-Cash Items
-29.11K 154.00 229.00 179.07K 650.98K 264.4K 72.31K 157.11K 183.00 223.00 480.00 75.78 785.00 1.64K 935.09K 1.15K 1.75K 20.38K 9.82K
Deferred Income Tax
n/a n/a n/a n/a n/a -264.25K -72.15K n/a n/a n/a n/a -1.35K n/a n/a 1.35K -5.23K n/a 3.24K 1.99K
Change in Working Capital
135.8K -411.75K 275.95K 635.59K -333.89K 158.88K 536.3K 1.67M -284.09K 106.16K 301.79K 90.16K -129.24K -447.44K 701.08K -425.25K 366.79K -276.55K -205.1K
Operating Cash Flow
-1.99M -2.19M -2.59M -1.48M -1.94M -1.72M -1.17M -1.5M -1.74M -1.4M -1.03M -1.4M -1.66M -2.11M -724.23K -2.23M -1.43M -2.32M -2.24M
Capital Expenditures
n/a n/a -46.76K -98.16K -44.63K -5.47K -8.29K -2.57K -59.3K -45.34K -44.51K -75.36K -39.32K -185.35K -24.31K -84.64K -110.56K -8.58K -34.98K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -46.76K -98.16K -44.63K -5.47K -8.29K -2.57K -59.3K -45.34K -44.51K -75.36K -39.32K -185.35K -24.31K -84.64K -110.56K -8.58K -34.98K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a -23.84K -70.95K -70.12K -69.29K -23.97K -71.34K -70.5K -69.67K -1.12M -47.03K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 3.12M n/a n/a n/a n/a n/a n/a n/a 37.41K n/a -37.41K n/a n/a n/a 41.02K -41.02K
Financial Cash Flow
575.5K 2.28M 1.71M 3.12M n/a n/a n/a n/a n/a -23.84K -70.95K -32.71K -69.29K -61.38K -71.34K -70.5K 6.05M -1.07M 10.35M
Net Cash Flow
-1.42M 91.76K -931.49K 1.54M -1.99M -1.72M -1.18M -1.5M -1.8M -1.47M -1.15M -1.51M -1.76M -2.36M -819.88K -2.38M 4.51M -3.4M 8.08M
Free Cash Flow
-1.99M -2.19M -2.64M -1.58M -1.99M -1.72M -1.18M -1.5M -1.8M -1.45M -1.08M -1.47M -1.69M -2.3M -748.54K -2.31M -1.55M -2.32M -2.27M